Designer DNA drugs to soon conquer ailments like Alzheimer’s, Parkinson’s
25 March 2019 1:53 AM GMT
In a free wheeling chat with BusinessLine, Don W Cleveland, a renowned neurobiologist narrated the doubts, hopes and promises of these class of drugs in the future
- In a free wheeling chat with BusinessLine, Don W Cleveland, a renowned neurobiologist narrated the doubts, hopes and promises of these class of drugs in the future Designer DNA drugs that are promising to conquer modern world’s ailments of the aged like Alzheimer’s, Parkinson’s and others related to the human Brain are round the corner.
- They are targeted at inherited ALS (Amytropic Lateral Sclerosis), Spinal Muscular Atrophy (SMA), Huntington’s disease and Alzheimer’s.
- While Ionis Pharmaceuticals, a startup in the United States (US) is involved in four of these promising drugs, Roche, the Pharma major is carrying out phase-3 trials for Huntington
- In December 2018 he received the $3million Breakthrough Prize in Life Sciences for his development of a new class of “designer DNA
Next Story
